articleTop 10% cited

Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989–1999

Gynecologic Oncology · 2004 · Vol. 93(1) · pp. 204–208

Sandra E. Brooks✉(University of Maryland, Baltimore)Min Zhan(University of Maryland, Baltimore)Timothy R. Coté(United States Food and Drug Administration)Claudia R. Baquet(University of Maryland, Baltimore)

View via DOI Publisher page

Uterine Myomas and Treatments Endometrial and Cervical Cancer Treatments Gynecological conditions and treatmentsMedicineCarcinosarcomaLeiomyosarcomaSarcomaUterine sarcomaEndometrial stromal sarcomaIncidence (geometry)EpidemiologySurveillance, Epidemiology, and End ResultsGynecology

MeSH terms

AdultAge FactorsAgedCarcinosarcomaFemaleHumansLeiomyosarcomaMiddle AgedUterine NeoplasmsSarcoma, Endometrial StromalSEER ProgramBlack PeopleWhite People

Citations

517

FWCI

11.14

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)